Enhabit, Inc. (NYSE:EHAB) Receives Consensus Rating of “Hold” from Brokerages

Enhabit, Inc. (NYSE:EHAB) has been given a consensus recommendation of “Hold” by the nine research firms that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $13.5714.

Several brokerages have weighed in on EHAB. Jefferies Financial Group lowered Enhabit from a “buy” rating to a “hold” rating and upped their target price for the stock from $12.50 to $13.80 in a research report on Monday, February 23rd. UBS Group reissued a “neutral” rating and issued a $13.80 price target (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th. Leerink Partners increased their price objective on Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a report on Monday, February 23rd. Citigroup reaffirmed a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Finally, Truist Financial set a $13.80 target price on shares of Enhabit in a research report on Monday, February 23rd.

Enhabit Trading Down 0.0%

Shares of NYSE:EHAB opened at $13.66 on Friday. The firm has a fifty day moving average of $12.26 and a two-hundred day moving average of $9.97. The firm has a market capitalization of $692.58 million, a P/E ratio of -151.72 and a beta of 1.56. Enhabit has a 12-month low of $6.47 and a 12-month high of $13.69. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76.

Enhabit (NYSE:EHAB) last posted its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The business had revenue of $270.40 million for the quarter, compared to the consensus estimate of $270.56 million. On average, equities analysts expect that Enhabit will post 0.22 EPS for the current fiscal year.

Insider Transactions at Enhabit

In other Enhabit news, EVP Julie Diane Jolley sold 2,793 shares of the stock in a transaction on Monday, March 9th. The shares were sold at an average price of $13.63, for a total transaction of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This represents a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 3.40% of the company’s stock.

Institutional Trading of Enhabit

Large investors have recently made changes to their positions in the stock. AQR Capital Management LLC raised its stake in shares of Enhabit by 115.6% in the 1st quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock valued at $1,867,000 after acquiring an additional 115,456 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Enhabit by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock valued at $262,000 after purchasing an additional 1,248 shares during the last quarter. Jones Financial Companies Lllp raised its position in shares of Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after purchasing an additional 8,879 shares during the period. Empowered Funds LLC boosted its holdings in shares of Enhabit by 8.4% during the 1st quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock worth $1,675,000 after buying an additional 14,690 shares during the period. Finally, Acadian Asset Management LLC bought a new stake in shares of Enhabit during the 1st quarter worth $114,000.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.